Neuroscience
From The New York Times:
F.D.A. May Approve an Implant as a Treatment for Depression
By BARNABY J. FEDER
The New York Times
Published: February 4, 2005
The Food and Drug Administration said yesterday that it might permit an implantable electrical device for the treatment of epilepsy made by Cyberonics to also be marketed as a therapy for chronic depression that is resistant to other treatments.
The agency set a number of conditions on the tentative approval, and Cyberonics said it hoped to meet them before the end of May.
[ ... Read the full article ... ]
- Fda: Pcns Drugs Advisory Committee Results For Avid's Amyvid Alzheimer's Amyloid Neuroimaging Agent
A fuller report from The New York Times: F.D.A. Sees Promise in Alzheimer’s Imaging Drug By GINA KOLATA The New York Times Published: January 20, 2011 "A committee voted that the agency should approve the first test that can show the characteristic...
- Business World: Cyberonics And Neurostimulators (vagal Nerve Stimulator [vns])
Tomorrow's New York Times includes an article about the current state of FDA consideration of the Cyberonics VNS device for the treatment of depression. The article is notable for the number of interviews across the spectrum of opinion on this pending...
- Business World: Cyberonics And Neurostimulators (vagal Nerve Stimulator [vns])
From Reuters: Cyberonics falls as Senate probes FDA turnaround Thu May 19, 2005 10:07 AM ET CHICAGO (Reuters) - Shares of Cyberonics Inc. fell almost 13 percent on Thursday after the Senate Finance Committee began examining the FDA's handling of...
- Business World: Cyberonics And Neurostimulators
The Houston Press, which is an alternative news weekly in Houston, has a feature article this week about Cyberonics and its epilepsy device and its exploration of applications in mood disorders: Exposed Nerve Cyberonics has implanted its pacemaker in...
- Business World: Neuromodulation
This Canadian National Post report, among many yesterday and today, outlines ANS [company website] and Cyberonics [company website] issues: Advanced Neuromodulation Systems bids US$22 a share for Cyberonics Canadian Press (copyright) Thursday, September...
Neuroscience
Vagal Nerve Stimulator and Depression
From The New York Times:
F.D.A. May Approve an Implant as a Treatment for Depression
By BARNABY J. FEDER
The New York Times
Published: February 4, 2005
The Food and Drug Administration said yesterday that it might permit an implantable electrical device for the treatment of epilepsy made by Cyberonics to also be marketed as a therapy for chronic depression that is resistant to other treatments.
The agency set a number of conditions on the tentative approval, and Cyberonics said it hoped to meet them before the end of May.
[ ... Read the full article ... ]
- Fda: Pcns Drugs Advisory Committee Results For Avid's Amyvid Alzheimer's Amyloid Neuroimaging Agent
A fuller report from The New York Times: F.D.A. Sees Promise in Alzheimer’s Imaging Drug By GINA KOLATA The New York Times Published: January 20, 2011 "A committee voted that the agency should approve the first test that can show the characteristic...
- Business World: Cyberonics And Neurostimulators (vagal Nerve Stimulator [vns])
Tomorrow's New York Times includes an article about the current state of FDA consideration of the Cyberonics VNS device for the treatment of depression. The article is notable for the number of interviews across the spectrum of opinion on this pending...
- Business World: Cyberonics And Neurostimulators (vagal Nerve Stimulator [vns])
From Reuters: Cyberonics falls as Senate probes FDA turnaround Thu May 19, 2005 10:07 AM ET CHICAGO (Reuters) - Shares of Cyberonics Inc. fell almost 13 percent on Thursday after the Senate Finance Committee began examining the FDA's handling of...
- Business World: Cyberonics And Neurostimulators
The Houston Press, which is an alternative news weekly in Houston, has a feature article this week about Cyberonics and its epilepsy device and its exploration of applications in mood disorders: Exposed Nerve Cyberonics has implanted its pacemaker in...
- Business World: Neuromodulation
This Canadian National Post report, among many yesterday and today, outlines ANS [company website] and Cyberonics [company website] issues: Advanced Neuromodulation Systems bids US$22 a share for Cyberonics Canadian Press (copyright) Thursday, September...